198 related articles for article (PubMed ID: 25852859)
1. HIV medication-based urolithiasis.
Izzedine H; Lescure FX; Bonnet F
Clin Kidney J; 2014 Apr; 7(2):121-6. PubMed ID: 25852859
[TBL] [Abstract][Full Text] [Related]
2. High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients.
de Lastours V; Ferrari Rafael De Silva E; Daudon M; Porcher R; Loze B; Sauvageon H; Molina JM
J Antimicrob Chemother; 2013 Aug; 68(8):1850-6. PubMed ID: 23599359
[TBL] [Abstract][Full Text] [Related]
3. Urolithiasis associated with protease inhibitors.
Sundaram CP; Saltzman B
J Endourol; 1999 May; 13(4):309-12. PubMed ID: 10405912
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced renal calculi: epidemiology, prevention and management.
Daudon M; Jungers P
Drugs; 2004; 64(3):245-75. PubMed ID: 14871169
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitor-induced urolithiasis.
Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
[TBL] [Abstract][Full Text] [Related]
6. [Renal lithiasis due to indinavir].
Fernández JM; Robles JE; Regojo JM; López J; Sánchez D; Arocena J; Rosell D; Zudaire JJ; Berián JM
Rev Med Univ Navarra; 2002; 46(3):28-32. PubMed ID: 12685114
[TBL] [Abstract][Full Text] [Related]
7. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.
Hamada Y; Nishijima T; Watanabe K; Komatsu H; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
Clin Infect Dis; 2012 Nov; 55(9):1262-9. PubMed ID: 22820542
[TBL] [Abstract][Full Text] [Related]
8. Indinavir urolithiasis.
Wu DS; Stoller ML
Curr Opin Urol; 2000 Nov; 10(6):557-61. PubMed ID: 11148725
[TBL] [Abstract][Full Text] [Related]
9. Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients.
Kalaitzis C; Dimitriadis G; Tsatidis T; Kuntz R; Touloupidis S; Kelidis G
Int Urol Nephrol; 2002; 34(1):13-5. PubMed ID: 12549631
[TBL] [Abstract][Full Text] [Related]
10. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
van Heeswijk RP; Veldkamp A; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
Antivir Ther; 2001 Dec; 6(4):201-29. PubMed ID: 11878403
[TBL] [Abstract][Full Text] [Related]
11. [Urinary lithiasis secondary to medication in HIV+ patients receiving Indinavir].
Juan Escudero JU; López Alcina E; Ordoño Domínguez F; Fabuel Deltoro M; Serrano de la Cruz Torrijos F; Montoliu García A; Ramada Benlloch F; Marqués Vidal E
Arch Esp Urol; 2008; 61(1):35-40. PubMed ID: 18405026
[TBL] [Abstract][Full Text] [Related]
12. The etiology of urolithiasis in HIV infected patients.
Nadler RB; Rubenstein JN; Eggener SE; Loor MM; Smith ND
J Urol; 2003 Feb; 169(2):475-7. PubMed ID: 12544290
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway.
Taura M; Kariya R; Kudo E; Goto H; Iwawaki T; Amano M; Suico MA; Kai H; Mitsuya H; Okada S
Free Radic Biol Med; 2013 Dec; 65():778-788. PubMed ID: 23973637
[TBL] [Abstract][Full Text] [Related]
14. [Indinavir urolithiasis in HIV-positive patients. Treatment and prophylaxis].
Kalaitzis C; Touloupidis S; Patris E; Lehrich K; Kuntz RM
Urologe A; 2004 Feb; 43(2):168-71. PubMed ID: 14991118
[TBL] [Abstract][Full Text] [Related]
15. [Drug-induced urinary calculi in 1999].
Daudon M
Prog Urol; 1999 Dec; 9(6):1023-33. PubMed ID: 10658246
[TBL] [Abstract][Full Text] [Related]
16. Urolithiasis associated with the protease inhibitor indinavir.
Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.
Poveda E; de Mendoza C; Martin-Carbonero L; Corral A; Briz V; González-Lahoz J; Soriano V
J Antimicrob Chemother; 2007 Oct; 60(4):885-8. PubMed ID: 17646201
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.
McLaughlin MM; Guerrero AJ; Merker A
Drugs Context; 2018; 7():212519. PubMed ID: 29623097
[TBL] [Abstract][Full Text] [Related]
19. Ureteral Obstruction Due to Radiolucent Atazanavir Ureteral Stones.
Grant MT; Eisner BH; Bechis SK
J Endourol Case Rep; 2017; 3(1):152-154. PubMed ID: 29098200
[No Abstract] [Full Text] [Related]
20. Urolithiasis associated with indinavir in a patient with spinal cord injury.
Yudkoff BL; Linsenmeyer TA; Oakley A; Kirshblum S
J Spinal Cord Med; 2004; 27(3):263-5. PubMed ID: 15478531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
